Helotes, TX, United States of America

Joseph A McDonough

This inventor holds 19 USPTO granted patents and 5 published patent applications, primarily in Pharmaceutical Formulations. Top assignees: Southwest Research Institute, The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., US Government as Represented by the Secretary of the Army. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph A McDonough. Retrieved from https://idiyas.com/inventor/joseph-a-mcdonough

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 78(Granted Patents)


Company Filing History:


Years Active: 2007-2024

Loading Chart...
Areas of Expertise:
Cyanide Antidote
Coronavirus Inhibitors
Antiviral Drugs
Liposomal Vaccine
Pharmaceutical Salts
Drug Delivery
Biodegradable Microparticles
Nanosuspensions
Oxime Formulations
Heat-Sensitive Agents
Calcium Phosphate
Bioactive Formulations
19 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Joseph A. McDonough

Introduction: Joseph A. McDonough is a prominent inventor based in Helotes, Texas, known for his significant contributions to science and medical technology. With an impressive portfolio of 19 patents, McDonough has made strides in developing solutions to critical health issues, showcasing his dedication to innovation and public safety.

Latest Patents: Among his latest inventions, McDonough has developed compositions of dimethyl trisulfide (DMTS) as a cyanide antidote. This groundbreaking work focuses on creating stable compositions of DMTS suitable for treating cyanide intoxication. The stability of these compositions makes them particularly applicable for use in autoinjectors, ensuring timely and effective medical intervention. In addition, he has crafted inhibitors for coronavirus, targeting SARS-CoV-1, SARS-CoV-2 (Covid-19), MERS-CoV, and their variants. His work includes methods for treating individuals suffering from these respiratory diseases, highlighting his commitment to addressing contemporary health challenges.

Career Highlights: Joseph A. McDonough's career has been marked by his engagement with esteemed institutions such as the Southwest Research Institute and The Henry M. Jackson Foundation for the Advancement of Military Medicine. His experiences in these organizations have shaped his innovative thinking and expanded the impact of his inventions.

Collaborations: Throughout his career, McDonough has had the opportunity to collaborate with noteworthy colleagues, including Hong Dixon and Larry Allen Cabell. These partnerships have played a crucial role in advancing his research and enhancing the efficacy of his patented solutions.

Conclusion: Joseph A. McDonough's contributions to the fields of medicine and health through his inventions are significant. His ongoing work exemplifies the spirit of innovation and highlights the importance of patented technologies in solving complex problems. As we recognize his achievements, we look forward to the future advancements he will undoubtedly continue to pursue.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…